TALI Digital Limited announced appointment of Dr. David Brookes as Non-Executive Director and announced resignation of Mark Simari. Dr. Brookes has extensive experience in the health and biotechnology industries, first becoming involved in the biotechnology sector in the late 1990's as a consultant. Dr. Brookes has since held Board positions in numerous ASX listed biotechnology companies, including Chairman of genomics solutions company, RHS Ltd, which was acquired by PerkinElmer Inc. in June 2018. Simari's effective resignation date is 29 June 2020 and Dr. Brookes' commencement date is 29 June 2020.